Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Receivables - Net (2020 - 2024)

Historic Receivables - Net for IDEAYA Biosciences (IDYA) over the last 5 years, with Q4 2024 value amounting to $3000.0.

  • IDEAYA Biosciences' Receivables - Net fell 8333.33% to $3000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $3000.0, marking a year-over-year decrease of 8333.33%. This contributed to the annual value of $3000.0 for FY2024, which is 8333.33% down from last year.
  • According to the latest figures from Q4 2024, IDEAYA Biosciences' Receivables - Net is $3000.0, which was down 8333.33% from $20000.0 recorded in Q3 2024.
  • IDEAYA Biosciences' 5-year Receivables - Net high stood at $6.7 million for Q3 2023, and its period low was $1000.0 during Q2 2024.
  • Its 5-year average for Receivables - Net is $1.2 million, with a median of $468000.0 in 2023.
  • In the last 5 years, IDEAYA Biosciences' Receivables - Net surged by 23880.16% in 2022 and then plummeted by 9970.16% in 2024.
  • Quarter analysis of 5 years shows IDEAYA Biosciences' Receivables - Net stood at $1.9 million in 2020, then plummeted by 41.24% to $1.1 million in 2021, then plummeted by 80.87% to $211000.0 in 2022, then tumbled by 91.47% to $18000.0 in 2023, then plummeted by 83.33% to $3000.0 in 2024.
  • Its Receivables - Net stands at $3000.0 for Q4 2024, versus $20000.0 for Q3 2024 and $1000.0 for Q2 2024.